retatrutide clinical trial stage status approval: FDA status, results, and when it could be available Triple hormone receptor agonist retatrutide – A Study of Retatrutide (LY3437943)
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7






























